标题
Repurposing Vorinostat for the Treatment of Disorders Affecting Brain
作者
关键词
-
出版物
NEUROMOLECULAR MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-05
DOI
10.1007/s12017-021-08660-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
- (2020) Bettina Zierfuss et al. Annals of Clinical and Translational Neurology
- Cognitive Improvement by Vorinostat through Modulation of Endoplasmic Reticulum Stress in a Corticosterone-Induced Chronic Stress Model in Mice
- (2020) Athira K V et al. ACS Chemical Neuroscience
- Differential modulation of GR signaling and HDACs in the development of resilient/vulnerable phenotype and antidepressant-like response of vorinostat
- (2020) Athira K V et al. PSYCHONEUROENDOCRINOLOGY
- A combination of curcumin, vorinostat and silibinin reverses Aβ-induced nerve cell toxicity via activation of AKT-MDM2-p53 pathway
- (2019) Jia Meng et al. PeerJ
- An overview of the heterogeneity of major depressive disorder: Current knowledge and Future prospective
- (2019) Athira K V et al. Current Neuropharmacology
- Early Histone Deacetylase Inhibition Mitigates Ischemia/Reperfusion Brain Injury by Reducing Microglia Activation and Modulating Their Phenotype
- (2019) Shuyuan Li et al. Frontiers in Neurology
- Crafting Carbazole-Based Vorinostat and Tubastatin-A-like Histone Deacetylase (HDAC) Inhibitors with Potent in Vitro and in Vivo Neuroactive Functions
- (2019) R. Gajendra Reddy et al. ACS Omega
- Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice
- (2018) Athira KV et al. BEHAVIOURAL BRAIN RESEARCH
- HDAC inhibitors: a 2013–2017 patent survey
- (2018) Micaela Faria Freitas et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABAA Receptor γ2 Subunit
- (2018) Nela Durisic et al. Frontiers in Molecular Neuroscience
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Cognitive Function and Quality of Life in Vorinostat-Treated Patients Following Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplant
- (2018) Flora Hoodin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
- (2018) Malgorzata Ziemka-Nalecz et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities
- (2017) Elham Abdelmonem Mohamed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells
- (2017) Nina H. Pipalia et al. JOURNAL OF LIPID RESEARCH
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- Normalization of Hepatic Homeostasis in theNpc1nmf164Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat
- (2016) Andrew B. Munkacsi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients
- (2016) Sandra Almeida et al. NEUROBIOLOGY OF AGING
- The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression
- (2016) Elsa M. Meylan et al. NEUROPHARMACOLOGY
- Brain endothelial dysfunction in cerebral adrenoleukodystrophy
- (2015) Patricia L. Musolino et al. BRAIN
- Increasing progranulin levels and blockade of the ERK1/2 pathway: Upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia
- (2015) Carolina Alquezar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sustained-release nanoART formulation for the treatment of neuroAIDS
- (2015) Rahul Jayant et al. International Journal of Nanomedicine
- HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline models
- (2015) Eva Benito et al. JOURNAL OF CLINICAL INVESTIGATION
- Iron Complexation to Histone Deacetylase Inhibitors SAHA and LAQ824 in PEGylated Liposomes Can Considerably Improve Pharmacokinetics in Rats
- (2015) Yan Wang et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann–Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis
- (2015) Navin Rauniyar et al. MOLECULAR & CELLULAR PROTEOMICS
- HDAC Inhibitors as Novel Anti-Cancer Therapeutics
- (2015) Cristabelle Souza et al. Recent Patents on Anti-Cancer Drug Discovery
- The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Confers Acute Neuroprotection After Intracerebral Hemorrhage in Mice
- (2015) Sangeetha Sukumari-Ramesh et al. Translational Stroke Research
- Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease
- (2015) M. Cuadrado-Tejedor et al. Clinical Epigenetics
- Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
- (2014) Young Jun Seo et al. ACS Chemical Neuroscience
- Use of High-Resolution Volumetric MR Spectroscopic Imaging in Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor
- (2014) Hyunsuk Shim et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity
- (2014) Jia Meng et al. PLoS One
- Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
- (2014) Venkata Subba Atluri et al. Molecular Brain
- The promise and perils of HDAC inhibitors in neurodegeneration
- (2014) Alessandro Didonna et al. Annals of Clinical and Translational Neurology
- SAHA Enhances Proteostasis of Epilepsy-Associated α1(A322D)β2γ2 GABAA Receptors
- (2013) Xiao-Jing Di et al. CHEMISTRY & BIOLOGY
- Unique functional roles for class I and class II histone deacetylases in central nervous system development and function
- (2013) Michael J. Morris et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Epigenetics targeted protein-vorinostat nanomedicine inducing apoptosis in heterogeneous population of primary acute myeloid leukemia cells including refractory and relapsed cases
- (2013) Parwathy Chandran et al. Nanomedicine-Nanotechnology Biology and Medicine
- Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression
- (2013) Sam A Golden et al. NATURE MEDICINE
- Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
- (2013) Jeanine Jochems et al. NEUROPSYCHOPHARMACOLOGY
- SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
- (2013) Jesse E. Hanson et al. PLoS One
- A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests
- (2013) Frederick A. Schroeder et al. PLoS One
- Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis
- (2012) Zhenzhen Ge et al. EXPERIMENTAL NEUROLOGY
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)‐b‐poly(dl‐lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
- (2012) Elham A. Mohamed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene
- (2012) Yosuke Fujita et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Epigenetic mechanisms in neurological disease
- (2012) Mira Jakovcevski et al. NATURE MEDICINE
- Early prediction of response to Vorinostat in an orthotopic rat glioma model
- (2012) Li Wei et al. NMR IN BIOMEDICINE
- Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
- (2012) Androniki Kretsovali et al. Stem Cells International
- Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage
- (2011) SH Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
- (2011) Sabine Mueller et al. CANCER LETTERS
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription
- (2011) Basar Cenik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events
- (2011) Shusaku Uchida et al. NEURON
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition
- (2010) Sarah K. Kidd et al. BRAIN RESEARCH
- SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
- (2010) Markus Riessland et al. HUMAN MOLECULAR GENETICS
- Depression in Cerebral Glioma Patients: A Systematic Review of Observational Studies
- (2010) A. G. Rooney et al. JNCI-Journal of the National Cancer Institute
- Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease
- (2010) Tapio Nuutinen et al. NEUROSCIENCE LETTERS
- HDACi – Targets beyond chromatin
- (2009) Marc Buchwald et al. CANCER LETTERS
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
- (2009) Antonello Mai et al. CURRENT PHARMACEUTICAL DESIGN
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Antidepressant Actions of Histone Deacetylase Inhibitors
- (2009) H. E. Covington et al. JOURNAL OF NEUROSCIENCE
- Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?
- (2009) D. R. Grayson et al. MOLECULAR PHARMACOLOGY
- HDAC2 negatively regulates memory formation and synaptic plasticity
- (2009) Ji-Song Guan et al. NATURE
- Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease
- (2009) Mark Kilgore et al. NEUROPSYCHOPHARMACOLOGY
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- α-Mercaptoketone based histone deacetylase inhibitors
- (2008) Paul L. Wash et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
- (2008) T ABEL et al. CURRENT OPINION IN PHARMACOLOGY
- Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
- (2008) Jan Hauke et al. HUMAN MOLECULAR GENETICS
- Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- (2008) Aleksey G. Kazantsev et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started